Results 21 to 30 of about 267,471 (248)

Prevalence of Comorbidity between Dry Eye and Allergic Conjunctivitis: A Systematic Review and Meta-Analysis

open access: yesJournal of Clinical Medicine, 2022
This systematic review aimed to determine the comorbid dry eye (DE) and allergic conjunctivitis (AC) prevalence. We searched PubMed and EMBASE for articles published until 22 March 2022, combining the terms “(dry eye OR keratoconjunctivitis sicca) AND ...
Yasutsugu Akasaki   +17 more
semanticscholar   +1 more source

Effects of rAmb a 1-Loaded PLGA-PEG Nanoparticles in a Murine Model of Allergic Conjunctivitis

open access: yesMolecules, 2022
Ambrosia artemisiifolia (Amb a) contains many allergens. Allergic conjunctivitis caused by Ambrosia artemisiifolia and its related allergen-specific immunotherapy (AIT) are seldom studied at present.
Hui Cao   +7 more
semanticscholar   +1 more source

Air pollution and meteorological conditions significantly contribute to the worsening of allergic conjunctivitis: a regional 20-city, 5-year study in Northeast China

open access: yesLight: Science & Applications, 2021
This study is the first to explore the potential associations among allergic conjunctivitis (AC), air pollution, and meteorological conditions in Northeast China.
Cheng-wei Lu   +6 more
semanticscholar   +1 more source

Association of Allergic Conjunctivitis With Health-Related Quality of Life in Children and Their Parents.

open access: yesJAMA ophthalmology, 2021
Importance Allergic conjunctivitis (AC) is one of the most common allergic diseases and is especially problematic in children and adolescents. The course of AC is generally prolonged and often recurs. Understanding the health-related quality of life (QOL)
Shi-yao Zhang   +7 more
semanticscholar   +1 more source

Corneal biomechanical changes in allergic conjunctivitis

open access: yesEye and Vision, 2021
To explore corneal biomechanical changes, identify related factors and determine early indicators of keratoconus (KC) development risk in allergic conjunctivitis (AC) patients. A total of 50 patients, including 20 eyes without AC and 30 eyes with AC were
Qian Wang   +6 more
semanticscholar   +1 more source

Serum IgE reduction and paradoxical eosinophilia associated with allergic conjunctivitis after dupilumab therapy

open access: yesJournal of Ophthalmic Inflammation and Infection, 2021
To the Editor, Introduction Dupilumab is a fully human monoclonal antibody against the α subunit of the interleukin (IL)-4 receptor (IL-4Rα), and inhibits IL-4 and IL-13 signalling pathways.
Ayaka Kimura   +3 more
semanticscholar   +1 more source

Production profile of lipid mediators in conjunctival lavage fluid in allergic and infectious conjunctivitis in guinea pigs

open access: yesFrontiers in Allergy, 2023
IntroductionConjunctivitis is a major ocular disease classified into allergic or infectious. The pathological features of conjunctivitis are not fully understood despite its high morbidity rate; thus, its differentiation can be difficult.Materials and ...
Akane Hayashi   +6 more
doaj   +1 more source

Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis [PDF]

open access: yes, 2015
Peer reviewedPublisher ...
Azuara-Blanco, Augusto   +4 more
core   +1 more source

Major considerations and clinical findings on the allergic conjunctivitis: a narrative and systematic review [PDF]

open access: yes, 2022
Introduction: Allergic conjunctivitis (AC) is a disease of increasing prevalence, affecting children and adults, with progressive loss of quality of life.
Daher, Isabelle Dalloul   +5 more
core   +2 more sources

Development and preliminary validation of a new screening questionnaire for identifying atopic children [PDF]

open access: yes, 2017
Background: Allergic diseases represent a frequent and increasing condition affecting children. A screening questionnaire allowing an easy identification of children with symptoms of allergic diseases may improve management and clinical outcome.
BRUSCOLINI, ALICE   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy